LAVA Therapeutics N.V. (LVTX)
1.740
0.00 (0.00%)
Inactive · Last trade price on Nov 20, 2025
LAVA Therapeutics Revenue
LAVA Therapeutics had revenue of $4.99M in the twelve months ending September 30, 2025, down -32.06% year-over-year. In the year 2024, LAVA Therapeutics had annual revenue of $11.98M with 77.01% growth.
Revenue (ttm)
$4.99M
Revenue Growth
-32.06%
P/S Ratio
9.38
Revenue / Employee
$146,765
Employees
34
Market Cap
45.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.98M | 5.21M | 77.01% |
| Dec 31, 2023 | 6.77M | -12.62M | -65.09% |
| Dec 31, 2022 | 19.39M | 14.04M | 262.45% |
| Dec 31, 2021 | 5.35M | 1.60M | 42.78% |
| Dec 31, 2020 | 3.75M | - | - |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLVTX News
- 14 days ago - LAVA Announces Exceeding Minimum Condition in Tender Offer and Intent to Delist from Nasdaq - GlobeNewsWire
- 17 days ago - LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline - GlobeNewsWire
- 2 months ago - LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025 - GlobeNewsWire
- 3 months ago - LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - LAVA Reports First Quarter 2025 Financial Results, Provides Business Update - GlobeNewsWire
- 8 months ago - LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation - GlobeNewsWire
- 8 months ago - LAVA Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 9 months ago - Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang - Benzinga